# Campaign Plan: "Ship ePI in Seconds"

**Product:** Antigravity ePI Backend — stateless FHIR conversion API for EMA ePI submissions
**Prepared:** 2026-04-14
**Campaign window:** May 1 – October 31, 2026 (26 weeks)
**Upstream docs:** `FEATURE_SPEC.md`, `COMPETITIVE_ANALYSIS.md`, `MARKETING_COMPETITIVE_BRIEF.md`

---

## 1. Campaign Overview

**Campaign name:** **"Ship ePI in Seconds"**

**One-sentence summary:** A 26-week launch campaign that claims the "developer-first, API-native, fidelity-scored" category for EMA ePI conversion — ahead of EMA's Q3/Q4 2026 go-live and Veeva's August 2026 AI Agents release.

**Primary objective (SMART).** Drive **200 sandbox signups**, **30 qualified pilots** (design partners + CRO OEM prospects), and **8 paid contracts** by October 31, 2026 — generating **€2M in signed + pipeline ARR** heading into the EMA mandate go-live.

**Secondary objectives.**
- **Category creation.** Establish "FHIR conversion API" and "FHIR fidelity score" as recognized terms in the reg-tech narrative, measured by third-party (analyst, blog, LinkedIn) adoption of the phrases.
- **Developer mindshare.** Become the default reference implementation discussed at HL7 FHIR Connectathons and Vulcan Accelerator calls — measured by GitHub stars (target 500+) and Connectathon mentions.
- **Veeva-complementary narrative.** Secure at least one public Vault RIM customer using our API alongside Vault, and publish a reference architecture before Veeva AI Agents GA (August 2026).

---

## 2. Target Audience

### Primary segment — "The Regulatory Engineer"

**Who.** Platform / engineering leads at **mid-cap MAHs (50–500 products)**, **CROs**, and **reg-tech integrators** building ePI-capable tooling for their own customers.
- Titles: Head of Regulatory Technology, Reg-Ops Platform Lead, CTO of a mid-cap biotech, Principal Engineer at a CRO digital team.
- Company size: 200–5,000 FTE.
- Geographies: EU (especially Germany, Denmark, Switzerland, Netherlands, UK), US mid-cap biotech, India-based CRO delivery centres.

**Pain points.**
- EMA Q3/Q4 2026 go-live forcing an ePI decision with no in-house FHIR expertise.
- Existing vendors sell either black-box managed services (too slow, too opaque) or full RIM suites (too heavy, too long to implement).
- Auditability anxiety: "If an AI tool changes our SmPC, can we defend that to an EMA inspector?"
- Bandwidth: a 2–4 person platform team can't build FHIR conversion from scratch in 2026.

**Motivations.** Ship a production ePI pipeline in weeks; avoid multi-quarter Veeva/i4i implementation commitments; maintain developer ownership of the stack; have an auditable trail for QA.

**Where they spend time.** HL7 FHIR Community Slack, FHIR Connectathons, Vulcan Accelerator calls, LinkedIn (follows Glemser/Veeva/Docuvera but reads Hacker News), DIA Europe, RAPS, dev-conference YouTube, GitHub, Stack Overflow.

**Buying stage.** Aware of the mandate; actively researching options through Q2 2026; ready to pilot by Q3.

### Secondary segment — "The Reg-Ops Buyer"

**Who.** VP Regulatory Affairs / Head of Labeling at **mid-cap pharma** without deep Veeva commitment.
- Titles: VP Reg Affairs, Director Global Labeling, Head of Submissions.

**Pain points.** Mandate deadline pressure, CRO cost escalation, audit defensibility, reluctance to pay six-figure Vault RIM implementation fees for one use case.

**Buying stage.** Evaluating end-2026 submission strategy. Hands off technical decision to IT/platform team — which puts our primary segment in the driver's seat.

### Tertiary segment — "The CRO OEM Buyer"

**Who.** COO / CTO / Head of Service Delivery at CROs (Freyr, ProductLife, Accenture Life Sciences, mid-tier boutiques).

**Pain points.** Glemser/Veeva partnerships commoditise CRO margin. Labour cost of per-document conversion erodes profitability at volume.

**Motivation.** OEM our API to power their "ePI conversion" service; capture margin while appearing full-stack to their MAH clients.

---

## 3. Key Messages

### Core campaign message

**"Ship ePI in seconds — with an audit trail you can show the inspector."**

### Supporting messages (mapped to pain points)

1. **Speed.** *"Stateless API. DOCX to validated FHIR Bundle in under 30 seconds. No portal queue, no 24-hour SLA."*
   - *Proof:* Benchmark results on 10 public SmPC samples. Live demo on homepage.
2. **Auditability.** *"Every automated fix logged — rule ID, location, before/after. Your QA auditor gets a transformation ledger, not a black box."*
   - *Proof:* Published audit-log schema; sample validation report; GxP-reviewer testimonial.
3. **Transparency.** *"A fidelity score from 0 to 100 on every conversion, so you know exactly how much source content survived. No other vendor publishes this."*
   - *Proof:* Methodology paper; public fidelity benchmark vs. manual and managed-service baselines.
4. **Developer-shape.** *"REST API, OpenAPI docs, Docker image, Postman collection, sandbox. Integrated with your stack in an afternoon, not a quarter."*
   - *Proof:* Public `/docs`, free sandbox, sample Python + Node + cURL recipes.

### Message variations by channel

| Channel | Tone | Headline adapt |
|---|---|---|
| Homepage / landing | Confident, concrete, proof-first | "Ship ePI in seconds." |
| LinkedIn (reg-ops buyer) | Audit-defensible, outcome-led | "The fidelity score your auditor has been asking for." |
| Developer channels (HN, Dev.to, GitHub) | Engineering-honest, technical | "DOCX → FHIR ePI, sub-30s, with a recall score. Here's the API." |
| Paid search (intent-led) | Direct, comparison-framed | "Faster than Glemser. Lighter than Vault." |
| Conference booth / podcast | Story-driven | "We built the conversion engine we wished existed during our last submission." |

---

## 4. Channel Strategy

### Owned

| Channel | Why it fits | Format | Effort | Role |
|---|---|---|---|---|
| **Dev-focused website + API docs** | Primary buyer is an engineer; developer-first surface is our unclaimed space | Homepage, `/docs`, `/benchmarks`, `/pricing`, `/compare` (vs. Glemser, vs. Veeva) | High | Conversion hub |
| **Long-form "ePI Conversion Engineer's Handbook"** | No competitor owns the reference content for engineering audience | 60–80 page open Markdown/PDF, chaptered by pipeline phase | High | Top-of-funnel + SEO |
| **Engineering blog** | Reaches HN, Dev.to, Reddit r/fhir, LinkedIn | Weekly technical deep-dives: "How we scored 99% fidelity on Annex III," "Inside our FHIR auto-fixer" | Medium | Demand-gen + authority |
| **"The ePI Engineer" podcast/newsletter** | Category-defining audio + written voice | 10 eps in 6 months; guests: HL7 contributors, Gravitate Health, CRO CTOs | High | Mindshare + audience building |
| **LinkedIn (company + founder)** | Where reg-ops buyer lives | 3x/week: benchmark snippets, mandate countdown, customer quotes | Medium | Awareness + nurture |
| **GitHub** | Developer credibility signal | OSS sample SDKs (Python, TS), validator fixture repo, handbook source | Medium | Trust + inbound |
| **Email newsletter** | Sandbox users + handbook downloads | Bi-weekly; release notes, benchmark updates, customer stories | Low | Nurture + activation |

### Earned

| Channel | Why | Format | Effort |
|---|---|---|---|
| **HL7 FHIR Connectathons (36, 37, 38)** | Technical credibility; Vulcan/Gravitate Health ecosystem | Submit reference implementation, host a track | High |
| **DIA Europe 2026 (Reg Ops track)** | Primary reg-ops event in our window | Speaker slot + side-event dinner with design partners | High |
| **RAPS Convergence 2026 (US)** | US reg-ops audience | Speaker slot or sponsored panel | Medium |
| **Vulcan FHIR Accelerator calls** | Co-authorship alongside Glemser | Contribute a module; get mentioned in release notes | Medium |
| **Guest posts on reg-tech blogs** | IntuitionLabs, Pharmavibes, European Pharmaceutical Review | 1 post/month in campaign window | Medium |
| **Analyst briefings** | Gartner, IDC Life Sciences, Everest Group | Quarterly briefings; pitch "FHIR conversion API" as a category | Medium |
| **HL7 FHIR Community Slack, LinkedIn groups** | Where buyer lives when not at work | Organic contribution, answer questions, link to handbook | Low |

### Paid

| Channel | Why | Format | Effort | Budget guidance |
|---|---|---|---|---|
| **LinkedIn Ads (sponsored content + InMail)** | Precision targeting to reg-ops titles | Sponsored handbook downloads; InMail to Vault admins | Medium | 40% of paid |
| **Google Search Ads** | Capture high-intent keywords | Target "ePI FHIR conversion," "SmPC to FHIR," "FHIR conversion API," "DOCX to FHIR" | Medium | 25% of paid |
| **Sponsored content — reg-tech publications** | IntuitionLabs, European Pharmaceutical Review, Pharmavibes, BioPharma Dive | Native article on fidelity-score benchmark | Low | 15% of paid |
| **Veeva R&D Summit 2026 sponsorship** (Boston May 19–20 or Copenhagen May 28–29) | Catches Vault customers mid-evaluation | Sponsored talk on "embedding FHIR conversion inside Vault RIM" | High | 15% of paid |
| **DIA Europe / RAPS booth or sponsorship** | Reg-ops buyer convening | Booth or co-hosted side event | High | 5% of paid |

### Channel budget allocation (recommended for a €250K total campaign)

| Category | % | € | Notes |
|---|---:|---:|---|
| Paid acquisition (LinkedIn, Search, sponsored content) | 35% | €87,500 | Front-load to Jul–Sep during mandate-decision window |
| Events + sponsorships (Veeva Summit, DIA Europe, Connectathons) | 25% | €62,500 | Veeva Copenhagen is anchor investment |
| Content production (handbook, podcast, videos, benchmark) | 25% | €62,500 | Handbook + benchmark are one-time assets |
| Tools + tech (SEO, analytics, email, podcast hosting) | 5% | €12,500 | |
| Experimentation reserve | 10% | €25,000 | New channels, re-targeting, creative refresh |

---

## 5. Content Calendar (26 weeks)

Phases: **Phase 1 — Foundation** (Weeks 1–6), **Phase 2 — Launch** (Weeks 7–14), **Phase 3 — Mandate Sprint** (Weeks 15–22), **Phase 4 — Close + Learn** (Weeks 23–26).

| Wk | Dates (2026) | Content piece | Channel | Milestone | Dependency |
|---:|---|---|---|---|---|
| 1 | May 4 | Positioning doc + messaging framework finalised | Internal | Phase 1 kickoff | Brief approvals |
| 1 | May 4 | Landing page v1 ("Ship ePI in Seconds") live | Web | — | Design + copy |
| 2 | May 11 | Public sandbox + OpenAPI `/docs` live | Web + GitHub | **Milestone: developer surface GA** | P0 enterprise-readiness (auth) minimal |
| 2 | May 11 | "The Stripe of ePI conversion" founder LinkedIn post | LinkedIn | — | — |
| 3 | May 18 | "ePI Conversion Engineer's Handbook" Ch 1–2 published (open-source) | Web + GitHub | — | Writer + dev review |
| 3 | May 18 | Fidelity Score Benchmark v1 published (10 sample SmPCs, 4 vendors incl us) | Web + LinkedIn | **Milestone: benchmark as wedge** | 10 anonymised SmPCs + runs |
| 4 | May 25 | **Veeva R&D Summit Copenhagen sponsored talk** (May 28–29) | Event | **Milestone: first incumbent-buyer touch** | Speaker slot secured by Mar |
| 4 | May 25 | Post-event LinkedIn recap + press release | LinkedIn + PR | — | Event |
| 5 | Jun 1 | Handbook Ch 3–4 + first customer testimonial (design partner) | Web | — | Design partner signed |
| 5 | Jun 1 | "vs. Glemser" comparison page (honest, not hostile) | Web | — | — |
| 6 | Jun 8 | Paid launch: LinkedIn Sponsored Content starts | Paid | **Phase 1 complete** | Tracking live |
|  |  | — Phase 2: Launch —  |  |  |  |
| 7 | Jun 15 | **Press release: public launch of Antigravity ePI Backend** | PR + email | **Campaign launch** | Demo ready |
| 7 | Jun 15 | HN "Show HN" post + Dev.to cross-post | Earned | — | Sandbox live |
| 8 | Jun 22 | Podcast Ep 1: "Why we built an ePI API" (founder solo) | Podcast | **Podcast launch** | Show notes + distribution |
| 8 | Jun 22 | Handbook Ch 5–6 | Web | — | — |
| 9 | Jun 29 | Google Search Ads live on "ePI FHIR conversion," "SmPC to FHIR" | Paid | — | Landing page A/B tested |
| 9 | Jun 29 | Podcast Ep 2: HL7 FHIR Connectathon lead on ePI track | Podcast | — | Guest confirmed |
| 10 | Jul 6 | Webinar #1: "Building an ePI pipeline in an afternoon" (live demo) | Webinar | — | Registration LP live |
| 10 | Jul 6 | "vs. Veeva Vault RIM — complementary, not competitive" reference architecture | Web + LinkedIn | **Milestone: Veeva-complementary narrative shipped** | Integration tested |
| 11 | Jul 13 | Case study #1: mid-cap MAH design partner | Web + LinkedIn + PR | — | Customer approval |
| 11 | Jul 13 | Podcast Ep 3: Gravitate Health lead | Podcast | — | Guest |
| 12 | Jul 20 | **DIA Europe 2026 speaker session + side-event dinner** | Event | **Milestone: primary reg-ops audience** | Speaker slot |
| 12 | Jul 20 | Benchmark v2 update with 30 SmPCs and wider vendor set | Web | — | — |
| 13 | Jul 27 | Handbook Ch 7–9 (audit-log chapter, heavy GxP focus) | Web | — | QA-reviewer quote |
| 13 | Jul 27 | Podcast Ep 4: CRO CTO on OEM economics | Podcast | — | Guest |
| 14 | Aug 3 | Webinar #2: "Auditing an AI-converted FHIR doc" | Webinar | **Phase 2 complete** | QA SME |
|  |  | — Phase 3: Mandate Sprint (Veeva AI Agents launches; mandate approaches) —  |  |  |  |
| 15 | Aug 10 | **"Veeva AI Agents for RIM is live. Here's where we fit."** response post | LinkedIn + blog | **Responds to competitor launch** | Real agent capabilities analysed |
| 15 | Aug 10 | Paid: retargeting to handbook readers with "Book a pilot" CTA | Paid | — | — |
| 16 | Aug 17 | Case study #2: CRO OEM partner | Web + PR | — | CRO approval |
| 16 | Aug 17 | Podcast Ep 5: Vulcan FHIR Accelerator chair | Podcast | — | Guest |
| 17 | Aug 24 | Webinar #3: "EMA Q3 ePI go-live readiness" | Webinar | — | — |
| 17 | Aug 24 | Handbook Ch 10+ (multi-jurisdiction preview — Jordan, SPL scaffolding) | Web | — | — |
| 18 | Aug 31 | **EMA Q3 voluntary go-live (vaccines)** — launch day LinkedIn thread, first-day customer | Earned + LinkedIn | **External anchor date** | Paying customer volunteered |
| 19 | Sep 7 | Podcast Ep 6: vaccine-product reg-ops lead who shipped ePI | Podcast | — | Guest |
| 19 | Sep 7 | Sponsored article in European Pharmaceutical Review | Paid | — | — |
| 20 | Sep 14 | Webinar #4: "ePI for CROs — OEM playbook" | Webinar | — | — |
| 20 | Sep 14 | Handbook v1.0 final + PDF bundle | Web | **Handbook GA** | — |
| 21 | Sep 21 | Case study #3: Vault-adjacent customer (Veeva complementary) | Web + PR | — | — |
| 21 | Sep 21 | Podcast Ep 7: EMA PLM Portal product owner (if bookable) | Podcast | — | Stretch guest |
| 22 | Sep 28 | **HL7 FHIR Connectathon 38** — host the ePI track | Event | **Milestone: developer category leadership** | Prep |
|  |  | — Phase 4: Close + Learn —  |  |  |  |
| 23 | Oct 5 | Podcast Ep 8: Oncology reg lead ahead of Q4 oncology go-live | Podcast | — | — |
| 23 | Oct 5 | Paid: final push on "Book a pilot — pre-Q4 go-live" CTA | Paid | — | — |
| 24 | Oct 12 | Benchmark v3: expanded with all Q3 real submissions | Web | — | — |
| 24 | Oct 12 | Podcast Ep 9 + 10: two-part "What we learned from 30 pilots" | Podcast | **Podcast S1 wraps** | Internal data |
| 25 | Oct 19 | **EMA Q4 go-live (oncology)** — launch LinkedIn thread + press release | Earned | **External anchor date** | — |
| 25 | Oct 19 | Webinar #5: "Year-one of ePI — retrospective and 2027 outlook" | Webinar | — | — |
| 26 | Oct 26 | Campaign retrospective blog + 2027 roadmap teaser | Web + email | **Campaign close** | Data compiled |

---

## 6. Content Pieces Needed (full asset list)

### Must-have (P0)

1. **Landing page "Ship ePI in Seconds"** — H1, subhead, demo video, proof strip (benchmark numbers), primary CTA "Try the sandbox."
2. **Public OpenAPI docs + sandbox** — hosted reference, rate-limited free tier, Postman collection, Python/TS/cURL recipes.
3. **Fidelity Score Benchmark v1** — methodology, results, public JSON dataset.
4. **"ePI Conversion Engineer's Handbook"** — 10 chapters; open-source on GitHub; PDF distribution.
5. **Comparison pages** — `/compare/glemser` and `/compare/veeva` (honest, not hostile).
6. **Veeva-complementary reference architecture** — 1-pager + diagram + code sample.
7. **Launch press release** (Week 7) + EMA Q3 go-live release (Week 18) + Q4 release (Week 25).
8. **Podcast Season 1** — 10 episodes, cover art, RSS, Apple + Spotify distribution.
9. **5 webinars** — production + recording + gated replay.
10. **3 customer case studies** — mid-cap MAH, CRO OEM, Veeva-adjacent.
11. **Bi-weekly email newsletter** — 13 issues over the campaign.
12. **LinkedIn content plan** — ~3 posts/week = ~78 posts over 26 weeks; split company (40%) / founder (40%) / engineering-IC voice (20%).
13. **Paid creative** — LinkedIn Sponsored Content × 6 variants; Google Search Ads × 12 keywords × 3 copy variants.
14. **Event collateral** — Veeva Summit talk deck, DIA Europe talk deck, Connectathon demo, booth signage, one-pager.

### Nice-to-have (P1)

15. **Interactive "Score your SmPC" tool** — upload-and-score widget, lead-capture.
16. **Analyst briefing deck** — for Gartner / Everest / IDC Life Sciences quarterly meetings.
17. **Sample GitHub repos** — `epi-backend-python-sdk`, `epi-backend-ts-sdk`, `epi-fidelity-benchmark`.
18. **Explainer video (90s)** — homepage embed + LinkedIn + YouTube.
19. **Customer reference pack** — 2-min testimonial videos from each case-study customer.

### Stretch (P2)

20. **"State of ePI 2026" industry report** — end-of-campaign report using aggregated (anonymised) pilot data; becomes an annual Q1 2027 moment.
21. **Local-language landing pages** — German, French, Japanese for tertiary markets.

---

## 7. Success Metrics

### Primary KPI

**Qualified pilots signed × ARR in pipeline.**
- Target: **30 qualified pilots** (≥ mid-cap MAH or CRO, with a named submission or client use case) by Oct 31, 2026.
- Target: **€2M ARR in signed + pipeline** by campaign close.

### Secondary KPIs

| Metric | Target | Source | Cadence |
|---|---|---|---|
| Sandbox signups (top-of-funnel) | 200 | Web analytics + auth logs | Weekly |
| Handbook downloads | 1,500 | Forms + GitHub stars | Weekly |
| Podcast subscribers | 800 by end of campaign | Apple/Spotify stats | Monthly |
| LinkedIn follower growth | +3,000 | LinkedIn analytics | Monthly |
| GitHub stars on sample repos | 500+ | GitHub | Weekly |
| p95 latency on published API | <25s | Runtime telemetry | Weekly |
| Fidelity score ≥99% on benchmark | ≥85% of runs | Benchmark pipeline | Monthly |
| Organic traffic (owned keywords) | 5,000 visits/mo by Oct | GA / Plausible | Weekly |
| Share of voice on "ePI FHIR conversion" | From 0 → 15% vs. Glemser | Manual scoring, Supermetrics | Monthly |
| Veeva-customer pilots | ≥5 | CRM + case-study pipeline | Monthly |
| CRO OEM MoUs signed | ≥2 | CRM | Monthly |
| Press pickups in reg-tech pubs | ≥8 | PR tracking | Weekly |

### Measurement and reporting

- **Weekly:** acquisition funnel, ad performance, content performance → Friday 1-page dashboard.
- **Monthly:** full KPI scorecard, pilot pipeline review → first Monday of each month.
- **Quarterly:** campaign-vs-plan retrospective; reallocation of budget.
- **Instrumentation:** Plausible (privacy-compliant analytics) + internal Supabase events for sandbox + Amplitude for cohort retention (when connected).

---

## 8. Risks and Mitigations

1. **Risk: Veeva AI Agents for RIM (Aug 2026) absorbs the conversion use case.**
   - *Mitigation:* Position complementary, not competitive; ship reference architecture in Week 10 (Jul 6) before Veeva's Aug launch; target Vault-customer pilots as a specific segment with their own message track.
2. **Risk: EMA mandate slips beyond Q4 2026.**
   - *Mitigation:* Pre-book non-mandate-dependent use cases — multilingual PIL refresh, emc display integration, CRO OEM partnerships — so the funnel does not collapse if deadlines shift.
3. **Risk: Handbook and podcast take longer to produce than planned; Phase 2 launch slips.**
   - *Mitigation:* Handbook chapters ship incrementally; podcast books 3 guests ahead. Never block launch on content perfection.
4. **Risk: Paid channels underperform (LinkedIn CPL too high for the audience).**
   - *Mitigation:* Start with €5K/week budget for first 2 weeks; reallocate aggressively if CPL > €400; shift to sponsored content + events.
5. **Risk: Glemser responds with an API tier and commoditises the "API-first" position.**
   - *Mitigation:* Move first on benchmark transparency and handbook; race to claim category language before they ship.
6. **Risk: GxP concern dominates buyer conversation; "AI changed my label" triggers rejection.**
   - *Mitigation:* Lead with audit log; publish schema; secure a QA-signatory testimonial early; avoid leading with "AI-powered" in enterprise pitches.
7. **Risk: Engineering team can't sustain P0 feature shipping (auth, RBAC, SOC2 roadmap) alongside campaign.**
   - *Mitigation:* Freeze non-campaign feature work in Phase 2; resource the campaign with a dedicated DevRel + one content FTE; use fractional for podcast production and design.

---

## 9. Immediate Next Steps (this week)

1. **Approvals and budget sign-off.** Lock campaign budget (€250K recommended), campaign lead, and three content FTE (technical writer, podcast producer, designer).
2. **Messaging sign-off.** Approve the "Ship ePI in Seconds" tagline, the four supporting messages, and the "Stripe of ePI conversion" long-form positioning. Socialise with eng and CS.
3. **Veeva Summit Copenhagen.** Decision: pursue speaker slot (needs speaker accepted by early May — confirm viability).
4. **Design partners.** Identify and warm-start 3 mid-cap MAH + 2 CRO prospects for design-partner program by Week 4.
5. **Technical readiness.** Confirm sandbox + OpenAPI docs can ship by Week 2; SPOR code verification (open question from feature spec) in flight.
6. **Asset production kickoff.** Commission landing page design, podcast cover art, benchmark dataset curation, handbook Chapter 1 draft.
7. **Measurement stack.** Stand up Plausible, LinkedIn Ads tracking, Supermetrics (when MCP connected), and the weekly dashboard template.
8. **Analyst outreach.** Schedule Q2 briefings with Gartner (Life Sciences Cloud), Everest Group, IDC Life Sciences.

### Stakeholder approvals needed

| Stakeholder | Approval needed |
|---|---|
| CEO / founders | Budget, positioning, launch date |
| Head of Product | Feature readiness for launch (P0 spec + SPOR code sign-off) |
| Head of Engineering | Sandbox, OpenAPI, reference arch commitments |
| Legal / QA | Audit-log schema publication; customer-name usage |
| CS / Partnerships | Design partner and CRO OEM shortlist |

---

*End of plan.*

## Sources

- [2026 Veeva R&D and Quality Summit — Boston May 19–20, Copenhagen May 28–29, Boston Oct 20–21](https://www.veeva.com/events/rd-summit/)
- [Veeva Vault — Working with FHIR Messages (26R1+)](https://regulatory.veevavault.help/en/gr/48830/)
- [DIA Europe 2026 — Regulatory Operations track](https://www.diaglobal.org/en/flagship/dia-europe-2026/program/schedule/tracks/regulatory-operations)
- [DIA RSIDM Forum](https://www.extedo.com/events/dia-regulatory-submissions-information-and-document-management-forum-2026)
- [EMA Electronic product information (ePI)](https://www.ema.europa.eu/en/human-regulatory-overview/marketing-authorisation/product-information-requirements/electronic-product-information-epi)
- [EMRN ePI Implementation Guide v1.0.0](https://epi.ema.europa.eu/fhirig/)
- [ForgeStop — ePI Roadmap 2026 checklist](https://www.forgestop.com/blog/epi-roadmap-2026-pharma-compliance-checklist)
- [Glemser — On-demand HL7 FHIR conversion (benchmark competitor)](https://glemser.com/on-demand-hl7-fhir-conversion-services/)
- [Glemser — ePI Guide](https://glemser.com/epi-guide/)
- [MT-G — FHIR ePI service](https://www.mt-g.com/en/language-solutions/we-empower-you-to-reach-the-world/electronic-product-information)
- [READY! for ePI](https://www.ready4epi.com/)
- [Docuvera — Structured content ePI readiness](https://docuvera.com/blog/structured-content-epi-readiness/)
- [Gravitate Health ePI IG](https://www.gravitatehealth.eu/fhir-implementation-guide-for-epi-is-published/)
- [HL7 Vulcan ePI project](https://hl7vulcan.org/projects/electronic-product-information-epi/)
- [AI in Regulatory Affairs Market Report (Research and Markets)](https://www.researchandmarkets.com/reports/6226580/ai-in-regulatory-affairs-market-report)
